Skip to main content

Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study

Acta Diabetologica volume 52, pages 905–915 (2015)Cite this article

Abstract

Aims

To determine cut-off points of homeostasis model assessment of insulin resistance (HOMA-IR), β-cell function (HOMA-B), insulin sensitivity (HOMA-S), and fasting insulin for identifying the subjects with type 2 diabetes mellitus (T2DM) in Iranian adults using data from a prospective population-based study.

Methods

From participants of Tehran Lipid and Glucose Study, 4942 Iranian subjects, aged 20–86 years, were followed for incident T2DM. Fasting serum insulin was determined by the electrochemiluminescence immunoasaay. The associations between HOMA-IR, HOMA-B, HOMA-S, and fasting insulin and incident T2DM were evaluated using Cox proportional hazards models. The receiver operator characteristic curve analysis was used to determine the cut-off points of HOMA-IR, HOMA-B, HOMA-S, and fasting insulin.

Results

After 9.2 year follow-up, 346 (7.0 %) incident cases of T2DM were identified; the risk-factor-adjusted hazard ratios for HOMA1-IR, HOMA2-IR, HOMA1-B, HOMA2-B, HOMA1-S, HOMA2-S, and insulin were 1.15, 1.70, 0.732, 0.997, 0.974, 0.986, and 1.01 in women and 1.37, 1.67, 0.588, 0.993, 0.986, 0.991, and 1.06 in men, respectively (all p < 0.05 except for HOMA2-B in women). Optimal cut-off points for HOMA1-IR, HOMA2-IR, HOMA1-B, HOMA2-B, HOMA1-S, HOMA2-S, and insulin were 1.85, 1.41, 86.2, 72.5, 54.1, 63.7, and 11.13 µU/ml in women and 2.17, 1.18, 67.1, 74.6, 46.1, 74.1, and 9.16 µU/ml in men, respectively.

Conclusions

HOMA-IR, HOMA-B (except for HOMA2-B in women), HOMA-S, and fasting insulin were independent predictors of T2DM. Optimal cut-off points of HOMA-IR, HOMA-B, HOMA-S, and fasting serum insulin were determined from a population-based study for identifying incident T2DM.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP (2005) Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 54(2):333–339. doi: 10.2337/diabetes.54.2.333

    CAS  Article  PubMed  Google Scholar 

  2. Borai A, Livingstone C, Kaddam I, Ferns G (2011) Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol 11:158. doi:10.1186/1471-2288-11-158

    PubMed Central  Article  PubMed  Google Scholar 

  3. Perseghin G, Calori G, Lattuada G, Ragogna F, Dugnani E, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, Piemonti L (2012) Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up. Acta Diabetol 49(6):421–428. doi:10.1007/s00592-011-0361-2

    CAS  Article  PubMed  Google Scholar 

  4. Abbasi F, Okeke Q, Reaven GM (2014) Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR). Acta Diabetol 51(2):193–197. doi:10.1007/s00592-013-0461-2

    CAS  Article  PubMed  Google Scholar 

  5. Muniyappa R, Lee S, Chen H, Quon MJ (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294(1):E15–E26. doi:10.1152/ajpendo.00645.2007

    CAS  Article  PubMed  Google Scholar 

  6. Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F (2010) Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond) 7:26. doi:10.1186/1743-7075-7-26

    Article  Google Scholar 

  7. Després J-P, Marette A (1999) Obesity and insulin resistance: epidemiologic, metabolic, and molecular aspects. In: Reaven GM, Laws A (eds) Insulin resistance: the metabolic syndrome X. Humana Press Inc., Totowa, pp 51–81

    Chapter  Google Scholar 

  8. Meier JJ, Bonadonna RC (2013) Role of reduced beta-cell mass versus impaired beta-cell function in the pathogenesis of type 2 diabetes. Diabetes Care 36(Suppl 2):S113–S119. doi:10.2337/dcS13-2008

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  9. Khardori R (2013) Changing paradigms in type 2 diabetes mellitus. Indian J Endocrinol Metab 17(Suppl 1):S68–S71. doi:10.4103/2230-8210.119509

    PubMed Central  Article  PubMed  Google Scholar 

  10. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121):840–846. doi:10.1038/nature05482

    CAS  Article  PubMed  Google Scholar 

  11. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu S (2007) Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women’s Health Initiative Observational Study. Diabetes Care 30(7):1747–1752. doi:10.2337/dc07-0358

    PubMed Central  Article  PubMed  Google Scholar 

  12. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27(6):1487–1495. doi:10.2337/diacare.27.6.1487

    Article  PubMed  Google Scholar 

  13. Caumo A, Perseghin G, Brunani A, Luzi L (2006) New insights on the simultaneous assessment of insulin sensitivity and beta-cell function with the HOMA2 method. Diabetes Care 29(12):2733–2734. doi:10.2337/dc06-0070

    CAS  Article  PubMed  Google Scholar 

  14. Tohidi M, Ghasemi A, Hadaegh F, Derakhshan A, Chary A, Azizi F (2014) Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Clin Biochem 47(6):432–438. doi:10.1016/j.clinbiochem.2014.02.007

    CAS  Article  PubMed  Google Scholar 

  15. Perkins NJ, Schisterman EF (2006) The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 163(7):670–675. doi:10.1093/aje/kwj063

    PubMed Central  Article  PubMed  Google Scholar 

  16. Timoteo AT, Miranda F, Carmo MM, Ferreira RC (2014) Optimal cut-off value for homeostasis model assessment (HOMA) index of insulin-resistance in a population of patients admitted electively in a portuguese cardiology ward. Acta Med Port 27(4):473–479

    PubMed  Google Scholar 

  17. Esteghamati A, Ashraf H, Esteghamati AR, Meysamie A, Khalilzadeh O, Nakhjavani M, Abbasi M (2009) Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance. Diabetes Res Clin Pract 84(3):279–287. doi:10.1016/j.diabres.2009.03.005

    CAS  Article  PubMed  Google Scholar 

  18. Geloneze B, Vasques AC, Stabe CF, Pareja JC, Rosado LE, Queiroz EC, Tambascia MA (2009) HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS). Arq Bras Endocrinol Metabol 53(2):281–287

    Article  PubMed  Google Scholar 

  19. Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F, Garcia F, De Francisco A, Quintela AG (2013) Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 13:47. doi:10.1186/1472-6823-13-47

    PubMed Central  Article  PubMed  Google Scholar 

  20. Yamada C, Moriyama K, Takahashi E (2012) Optimal cut-off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non-diabetic Japanese subjects. J Diabetes Investig 3(4):384–387. doi:10.1111/j.2040-1124.2012.00194.x

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  21. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, Lee HC, Huh KB, Kim DJ (2006) Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 21(4):695–700

    PubMed Central  Article  PubMed  Google Scholar 

  22. Derakhshan A, Tohidi M, Arshi B, Khalili D, Azizi F, Hadaegh F (2014) Relationship of hyperinsulinaemia, insulin resistance and beta-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study. Diabet Med. doi:10.1111/dme.12560

    PubMed  Google Scholar 

  23. Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F (2014) Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS One 9(7):e102563. doi:10.1371/journal.pone.0102563

    PubMed Central  Article  PubMed  Google Scholar 

  24. Ainsworth BE, Jacobs DR Jr, Leon AS (1993) Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc 25(1):92–98

    CAS  Article  PubMed  Google Scholar 

  25. Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN, Bennett PH, Kuller LH (1990) Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13(4):401–411

    CAS  Article  PubMed  Google Scholar 

  26. Committee IPAQR (2005) Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ). Retrieved 15 Nov 2010

  27. Niemczyk S, Szamotulska K, Giers K, Jasik M, Bartoszewicz Z, Romejko-Ciepielewska K, Paklerska E, Gomolka M, Matuszkiewicz-Rowinska J (2013) Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients. Med Sci Monit 19:592–598. doi:10.12659/MSM.883978

    PubMed Central  Article  PubMed  Google Scholar 

  28. Bozorgmanesh M, Hadaegh F, Saadat N, Azizi F (2012) Fasting glucose cutoff point: where does the risk terminate? Tehran Lipid and Glucose Study. Acta Diabetol 49(5):341–348. doi:10.1007/s00592-011-0298-5

    CAS  Article  PubMed  Google Scholar 

  29. Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K (2004) A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 27(3):727–733

    Article  PubMed  Google Scholar 

  30. Rachek LI (2014) Free fatty acids and skeletal muscle insulin resistance. Prog Mol Biol Transl Sci 121:267–292. doi:10.1016/B978-0-12-800101-1.00008-9

    CAS  Article  PubMed  Google Scholar 

  31. Lorenzo C, Hazuda HP, Haffner SM (2012) Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study. J Clin Endocrinol Metab 97(3):793–799. doi:10.1210/jc.2011-2272

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  32. Hanley AJ, Wagenknecht LE, Norris JM, Bryer-Ash M, Chen YI, Anderson AM, Bergman R, Haffner SM (2009) Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia 52(10):2079–2086. doi:10.1007/s00125-009-1464-y

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  33. Soriguer F, Colomo N, Valdes S, Goday A, Rubio-Martin E, Esteva I, Castano L, Ruiz de Adana MS, Morcillo S, Calle A, Garcia-Fuentes E, Catala M, Gutierrez-Repiso C, Delgado E, Gomis R, Ortega E, Rojo-Martinez G (2014) Modifications of the homeostasis model assessment of insulin resistance index with age. Acta Diabetol 51(6):917–925. doi:10.1007/s00592-013-0523-5

    CAS  Article  PubMed  Google Scholar 

  34. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373(9682):2215–2221. doi:10.1016/S0140-6736(09)60619-X

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  35. Kuwana B, Urayama O, Kawai K (2002) Reference value and cut-off value for diagnosis of insulin resistance in type 2 diabetes mellitus. Rinsho Byori 50(4):398–403

    PubMed  Google Scholar 

  36. Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM (2012) Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One 7(12):e52036. doi:10.1371/journal.pone.0052036

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  37. Yamada C, Mitsuhashi T, Hiratsuka N, Inabe F, Araida N, Takahashi E (2011) Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J Diabetes Investig 2(5):373–376. doi:10.1111/j.2040-1124.2011.00113.x

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  38. Lee JG, Lee S, Kim YJ, Jin HK, Cho BM, Jeong DW, Park HJ, Kim JE (2009) Multiple biomarkers and their relative contributions to identifying metabolic syndrome. Clin Chim Acta 408(1–2):50–55. doi:10.1016/j.cca.2009.07.006

    CAS  Article  PubMed  Google Scholar 

  39. Mukai N, Doi Y, Ninomiya T, Hata J, Hirakawa Y, Fukuhara M, Iwase M, Kiyohara Y (2012) Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study. Diabet Med 29(1):99–106. doi:10.1111/j.1464-5491.2011.03378.x

  40. Evans JM (2009) Omentectomy, visceral fat, and insulin resistance. Obesity (Silver Spring) 17(11):1979. doi:10.1038/oby.2009.283

    Article  Google Scholar 

  41. Masharani U, Goldfine ID, Youngren JF (2009) Influence of gender on the relationship between insulin sensitivity, adiposity, and plasma lipids in lean nondiabetic subjects. Metabolism 58(11):1602–1608. doi:10.1016/j.metabol.2009.05.012

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  42. Usui C, Asaka M, Kawano H, Aoyama T, Ishijima T, Sakamoto S, Higuchi M (2010) Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people. J Nutr Sci Vitaminol (Tokyo) 56(2):109–116

    CAS  Article  Google Scholar 

  43. Hadaegh F, Bozorgmanesh M, Ghasemi A, Harati H, Saadat N, Azizi F (2008) High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 8(1):176

    PubMed Central  Article  PubMed  Google Scholar 

  44. Banerjee R, Ray K, Bhattacherjee S, Guha S, Banerjee I, Nath I (2014) A study of insulin resistance and its clinico-metabolic associations among apparently healthy individuals attending a tertiary care hospital. Ann Med Health Sci Res 4(5):823–828. doi:10.4103/2141-9248.141572

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  45. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, Sladek R, Rabasa-Lhoret R (2011) Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 35(7):971–981. doi:10.1038/ijo.2010.216

    CAS  Article  Google Scholar 

  46. Bell JA, Kivimaki M, Hamer M (2014) Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev 15(6):504–515. doi:10.1111/obr.12157

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  47. Boyko EJ, Jensen CC (2007) Do we know what homeostasis model assessment measures? If not, does it matter? Diabetes Care 30(10):2725–2728. doi:10.2337/dc07-1248

    Article  PubMed  Google Scholar 

  48. Manley SE, Luzio SD, Stratton IM, Wallace TM, Clark PM (2008) Preanalytical, analytical, and computational factors affect homeostasis model assessment estimates. Diabetes Care 31(9):1877–1883. doi:10.2337/dc08-0097

    PubMed Central  Article  PubMed  Google Scholar 

  49. Reaven G (2011) Wanted!: a standardized measurement of plasma insulin concentration. Arterioscler Thromb Vasc Biol 31(5):954–955. doi:10.1161/ATVBAHA.111.224790

    CAS  Article  PubMed  Google Scholar 

  50. Kato M, Noda M, Suga H, Nakamura T, Matsumoto M, Kanazawa Y (2012) Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study. Diabet Med 29(7):905–910. doi:10.1111/j.1464-5491.2012.03572.x

    PubMed Central  CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Grant No. 121 from the National Research Council of the Islamic Republic of Iran. The authors wish to thank laboratory staff of Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences.

Conflict of interest

This study was supported by Grant No.121 from the National Research Council of the Islamic Republic of Iran. We declare that we have no conflicts of interest.

Ethical standard

This study was approved by the institutional ethics committee of the Research Institute for the Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran [Dated 13th June 2014].

Human and animal rights disclosure

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. There are no animal rights issues as this is a clinical study.

Informed consent disclosure

Written informed consent was obtained from all participants before being included in the study.

Author information

Affiliations

  1. Endocrine Physiology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Asghar Ghasemi

  2. Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Asghar Ghasemi & Fereidoun Azizi

  3. Prevention of Metabolic Disorder Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No. 24, Parvaneh Street, Velenjak, P.O. Box 19395-4763, Tehran, Iran

    Maryam Tohidi, Arash Derakhshan, Mitra Hasheminia & Farzad Hadaegh

Authors
  1. Asghar Ghasemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryam Tohidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arash Derakhshan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mitra Hasheminia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fereidoun Azizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Farzad Hadaegh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maryam Tohidi.

Additional information

Managed by Massimo Porta.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ghasemi, A., Tohidi, M., Derakhshan, A. et al. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study. Acta Diabetol 52, 905–915 (2015). https://doi.org/10.1007/s00592-015-0730-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-015-0730-3

Keywords

  • Cut-off points
  • HOMA-IR
  • HOMA-B
  • HOMA-S
  • Insulin resistance
  • Type 2 diabetes
  • Epidemiology